Market Reports

Europe In Vitro Diagnostics Market: Projected Revenue of $18,647 Million by 2027 at 4.8% CAGR

The Europe in Vitro Diagnostics Market (IVD) was valued at $13,825 million in 2019, and is projected to reach $18,647 million at a CAGR of 4.8% from 2020 to 2027.

In vitro diagnostics (IVD) are defined as medical devices and reagents, which are used to examine specimens such as blood, urine, stool, tissues, and other body fluids, which are derived from human body to detect diseases, conditions, and infections. The tests can be performed in standalone laboratory, hospital-based laboratory, and point-of-care centers. Some significant technologies incorporated in in vitro diagnostics include polymerase chain reaction (PCR), microarray techniques, sequencing technology, and mass spectrometry, which are used for test sample preparation. Moreover, other techniques that are used to perform in vitro diagnosis involve clinical chemistry, tissue diagnostics, immunodiagnostics, hematology, and others. For instance, in clinical chemistry various tests are performed in laboratory such as liver panel test, lipid profile, thyroid function test, and others.

Our analysis involves the study of the market taking into consideration the impact of the COVID-19 pandemic. Please get in touch with us to get your hands on an exhaustive coverage of the impact of the current situation on the market. Our expert team of analysis will provide as per report customized to your requirement. For more connect with us at [email protected] or call toll free: +1-800-910-6452

Request a sample of this premium research:

Furthermore, a thyroid function test is performed by collecting blood from a patient, which is then tested to check the level of thyroid stimulating hormone (TSH) in blood. Similarly, others such as polymerase chain reaction (PCR) are used to detect the presence of infectious diseases such as HIV and hepatitis. In addition, constant innovations related to IVD products, service designs, and technology have encouraged doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines. For instance, some products that are used to perform various in vitro diagnostic tests using various technologies involve real time PCR detection systems, immunoassay systems, and others.

The major factor that contributes to the growth of the Europe in vitro diagnostic market include surge in number of in vitro diagnostic tests, which is attributable to rise in incidences of chronic and infectious diseases. Furthermore, growth in geriatric population, which is prone to immunological disorders is another major factor that boosts the growth of the market. Moreover, rise in use of personalized medicines in treatment of various chronic diseases such as cancer also fuels the growth of the market. In addition, increase in technological advancements associated with in vitro diagnostic products, technologies, and software & services boosts the market growth. However, stringent government regulations and unfavorable reimbursement policies are anticipated to restrict the growth of the Europe in vitro diagnostics market. On the contrary, potential for outsourcing present lucrative opportunities for key players in the Europe in vitro diagnostics market during the forecast period.

The report segments the market into product & service, technique, application, end user, and region. On the basis of product & service, it is segmented into chemicals & reagents, instruments, and services & software. On the basis of technique, it is categorized into immunodiagnostics, hematology, molecular diagnostics, tissue diagnostics, clinical chemistry, and others. In addition, the immunodiagnostics segment is further divided into types such as enzyme-linked immunosorbent assay (ELISA), rapid tests, enzyme-linked immunospot (ELISPOT), radioimmunoassay (RIA), and western blot. Moreover, the ELSIA segment is further divided into chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FIA), and colorimetric immunoassay (CI). Similarly, the molecular diagnostics segment is divided into polymerize chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), hybridization, DNA diagnostics, microarray, and others.

On the basis of application, the market is segmented into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and others. On the basis of end user, it is categorized into standalone laboratories, hospitals, academics & medical schools, point-of-care, and others. Country wise, the market is analyzed across Germany, France, the UK, Italy, Spain, and rest of Europe.

The major players in the in vitro diagnostics market are Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche AG, Siemens AG, QIAGEN N.V., Sysmex Corporation, and Thermo Fisher Scientific, Inc.

Request a discount on standard prices of this premium research:


• This report entails a detailed quantitative analysis along with the current Europe in vitro diagnostics market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessments.

• The market size and estimations are based on a comprehensive analysis of key developments in the industry.

• A qualitative analysis based on innovative products facilitates strategic business planning.

• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments

• By Product & Service
o Chemicals & Reagents
o Instruments
o Software and Services

• By Technique
o Immunodiagnostics
§ Enzyme-Linked Immunosorbent Assay (ELISA)
• Chemiluminescence Immunoassay (CLIA)
• Fluorescence immunoassay (FIA)
• Colorimetric Immunoassay (CI)
§ Rapid Tests
§ Enzyme-Linked ImmunoSpot (ELISPOT)
§ Radioimmunoassay (RIA)
§ Western Blot
o Hematology
o Molecular Diagnostics
§ Polymerize Chain Reaction (PCR)
§ Isothermal Nucleic Acid Amplification Technology (INAAT)
§ Hybridization
§ DNA diagnostics
§ Microarray
§ Others

o Tissue Diagnostics

o Clinical Chemistry

§ Basic Metabolic Panel

§ Liver Panel

§ Lipid Profile

§ Thyroid Function Panel

§ Electrolyte Panel

§ Specialty Chemicals

o Others

• By Application
o Infectious Diseases
o Cancer
o Cardiac Diseases
o Immune System Disorders
o Nephrological Diseases
o Gastrointestinal Diseases
o Others

• By End User
o Standalone Laboratories
o Hospitals
o Academic & Medical Schools
o Point-of-Care
o Others

• By Country
Rest of Europe

List of key players profiled in the report:
• Abbott Laboratories
• Becton, Dickinson and Company
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Danaher Corporation (Beckman Coulter, Inc.)
• F. Hoffmann-La Roche AG
• Siemens AG
• Sysmex Corporation
• Thermo Fisher Scientific, Inc.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
• DiaSorin
• Johnson & Johnson

About Us:
Big Market Research has a range of research reports from various publishers across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.
We are instrumental in providing quantitative and qualitative insights on your area of interest by bringing reports from various publishers at one place to save your time and money. A lot of organizations across the world are gaining profits and great benefits from information gained through reports sourced by us.

Contact us:
Mr. Abhishek Paliwal
5933 NE Win Sivers Drive, #205, Portland,
OR 97220 United States
Direct: +1-971-202-1575
Toll Free: +1-800-910-6452
E-mail: [email protected]

By Big Market Research

Driven by an objective of helping organizations achieve targets, competitive edge, and sustainable growth in the competitive world, Big Market Research was founded in 2013. Since its foundation, the firm has been striving for offering a qualitative and quantitative analysis of different markets through research reports. We have the world’s largest repository of research reports from various publishers that cover various categories and sub-categories.

Our prime objective is to cater to research requirements of organizations, investors, stakeholders, and new entrants by serving them with appropriate reports within their budgetary constraints. Our advanced search algorithms on the website will guide you in finding the reports you are looking for through a systematic approach. Along with offering appropriate research studies that align with the growth targets and strategies, we closely work with clients to understand their customization needs and publishers to convey the requirements and serve better.

Our passionate team of coordinators works around the clock to add value, save money & time, and serve with the best of their capabilities. We have been helping many of the Fortune 500 companies, small and medium businesses, and investors across the world to unlock their potential and take giant leaps. Above all, we strive to build healthy business relationships through cooperation, integrity, and customer-first approach.